AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.1800
-0.0077 (-4.10%)
At close: Oct 2, 2026, 4:00 PM
0.1790
-0.0010 (-0.56%)
After-hours: Oct 2, 2026, 7:53 PM EDT
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $5.48 million as of October 2, 2026. Its market cap has decreased by -26.03% in one year.
Market Cap
5.48M
Enterprise Value
-563.42K
1-Year Change
-26.03%
Ranking
Category
Stock Price
$0.18
ChartMarket Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $5.48M, a decrease of -86.58%. That is a compound annual growth rate of -6.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 5.48M | 69.96% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 6.24M |
| Lunai Bioworks | 5.89M |
| Cardio Diagnostics Holdings | 5.80M |
| Pulmatrix | 5.73M |
| Processa Pharmaceuticals | 5.40M |
| Kairos Pharma | 5.28M |
| Xenetic Biosciences | 5.25M |
| Liminatus Pharma | 5.24M |